Do liver metastases from gastric cancer contraindicate aggressive surgical resection? A 14-year single-center experience

Figure 2 Actual treatments for synchronous and metachronous liver metastases originated from gastric cancer. Seventeen patients had metachronous liver metastases originated from gastric cancer (LMGC) and 13 patients had synchronous LMGC. Seven patients with metachronous LMGC underwent liver resection (LR), and two of these seven patients subsequently received adjuvant chemotherapy. Four patients with metachronous LMGC received chemotherapy, and LR was subsequently performed. A partial response to neoadjuvant chemotherapy was achieve in two patients. Four of these 10 patients received adjuvant chemotherapy. Ten patients with synchronous LMGC underwent LR, and 9 of these 10 patients subsequently received adjuvant chemotherapy. Three patients with synchronous LMGC received chemotherapy, and LR was subsequently performed. All responses to neoadjuvant chemotherapy were categorized as partial responses. ¹One case of conversion was involved. LMGC: Liver metastases originated from gastric cancer; LR: Liver resection.